Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Contrarius Global Equity Fund Waystone Management Company (IE) Limited | “Beam holds patents over base editing (CRISPR 2.0) enabling precise base conversions without double-strand breaks, expanding targets and potentially improving safety. The company is advancing in-vivo programs for GSD1a and AATD (a large U.S. patient pool with limited options) while also partnering on additional modalities. If base editing proves safe/effective and delivery is reproducible, the platform could enable rapidly programmable precision medicines across multiple indications and be materially undervalued today. BSD Analysis: Beam is one of the few gene-editing names with real scientific horsepower, and base editing gives it a shot at cleaner, safer edits than first-gen CRISPR players still wrestling with off-target baggage. The story has been stuck in “show me” mode, but early human data and smoother regulatory interactions suggest Beam may finally be past the hand-waving stage. Big Pharma partnerships aren't charity — they're a signal that Beam's platform has legitimately differentiated IP and execution behind it. The cash runway is long, delivery tech is improving, and the pipeline has multiple shots on goal with real commercial potential. Bears still price Beam like a science experiment, but that disconnect widens every time the company hits a milestone. If even one program converts, BEAM goes from overlooked platform play to one of the most valuable precision-editing franchises in the space.” | BULL | Q3 2025 Sep 30, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
